Legacy Financial Group (Iowa)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-63
Closed -$4.72K 206
2023
Q3
$4.72K Buy
+63
New +$4.85K ﹤0.01% 387

Other funds holding GILD

Legacy Financial Group (Iowa)'s GILD Position: Q4 2023 in Review

Legacy Financial Group (Iowa) sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 63 shares — an estimated $4.72K sold.

Legacy Financial Group (Iowa) first reported a position in GILD in Q3 2023 and held it in 1 quarter. The position peaked at $4.72K in Q3 2023. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Legacy Financial Group (Iowa) reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Legacy Financial Group (Iowa) sold 63 Gilead Sciences shares in Q4 2023, an estimated $4.72K.
  • Legacy Financial Group (Iowa) first reported a position in Gilead Sciences in Q3 2023 and held it in 1 quarter.
  • Legacy Financial Group (Iowa)'s Gilead Sciences position peaked at $4.72K in Q3 2023.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Legacy Financial Group (Iowa)'s 13F filing for Q4 2023, filed 22 Jan 2024.